San Francisco-based Plenful, a workflow-automation platform for pharmacy and healthcare operations, introduced it secured $17 million in Sequence A funding lower than a yr after launching with $9 million in funding.Â
TQ Ventures led the spherical, with participation from Mitchell Rales (cofounder and chairman of Danaher), Susa Ventures and current buyers.Â
WHAT IT DOES
Plenful provides pharmacy technicians a no-code AI-enabled automation instrument for handbook and administrative workflow that features assist with doc information entry for pharmacy income cycle, referral orders, auditing and financial savings identification.Â
The corporate will use the funds to scale advertising, gross sales and product growth.
“We’re dedicated to reworking pharmacy and healthcare operations by addressing the handbook and administrative work that burdens the system, exacerbated by a big decline in graduating pharmacists, by progressive AI automation options,” Pleasure Liu, founder and CEO of Plenful, instructed MobiHealthNews in an e-mail.Â
“By streamlining operations and assuaging labor shortages, we empower healthcare groups to prioritize affected person care. Plenful is devoted to enhancing pharmacy care supply and shaping a extra environment friendly future for healthcare.”
MARKET SNAPSHOT
One other firm that secured funding this week for its workflow automation platform is SamaCare.Â
The corporate helps suppliers receive prior authorization for specialty drug drugs, test enrollment, and confirm advantages. It additionally makes use of information analytics to supply pharmaceutical firms with info on bettering remedy entry.Â
SamaCare additionally secured $17 million in funding.Â